~(99m)TcO_4~-甲状腺显像定量分析对甲状腺结节的鉴别诊断价值
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的
     探讨甲状腺显像定量分析对甲状腺良恶性结节的鉴别诊断价值,为患者的进一步治疗提供依据。
     方法
     对165例甲状腺结节患者进行甲状腺显像并依据术后病理结果分为良性结节组131例和恶性结节组34例。良性结节组分别按病理类型的不同进行分组。对良恶性结节两组患者,及良性结节组间患者的显像结果进行定量分析,测量①颈动脉-甲状腺通过时间(CTTT);②甲状腺结节部位与正常甲状腺部位的血流比(TNB/TB);③甲状腺结节部位与颈动脉部位的血流比(TNB/CAB);④摄锝指数(TN/SG);⑤摄锝比值(TN/T)。比较良恶性结节各项定量指标之间的差异及良性结节组间患者各项定量指标之间的差异。
     结果
     1、良恶结节组患者甲状腺显像各项指标的比较
     (1)恶性结节组的CTTT值明显低于良性结节组,差别有显著统计学意义(P<0.01);恶性结节组的TNB/TB值、TNB/CAB值明显高于良性结节组,差别有显著统计学意义(P<0.01);恶性结节组的TN/T值明显低于良性结节组,差别有显著统计学意义(P<0.01)。
     (2)恶性结节组的TN/SG值略低于良性结节组,差别无统计学意义(P>0.05)。
     2、良性结节组间患者甲状腺显像各项指标的比较
     良性结节组间CTTT值、TNB/TB值、TNB/CAB值、TN/SG值和TN/T值各项指标的比较均无显著统计学意义(P>0.05)。
     3、应用ROC曲线分析结果显示,甲状腺动态显像定量指标CTTT值,TNB/TB值及TNB/CAB值与静态显像定量指标TN/T值诊断甲状腺结节良恶性的敏感度、特异度分别为82.4%,73.1%;85.4%,85.3%;80%,61.8%;85.3%,66.2%。甲状腺动态显像定量指标CTTT,TNB/TB值,TNB/CAB值分别与静态显像定量指标TN/T值联合诊断甲状腺结节良恶性的敏感度、特异度和准确度为分别为:67.65%、90.00%、85.36%;70.59%、93.08%、88.41%;50.00%、88.45%、80.49%。
     结论
     1、甲状腺显像定量分析对甲状腺结节良恶性的鉴别具有重要的临床价值。
     2、甲状腺动态显像定量指标与甲状腺静态显像定量指标联合诊断对甲状腺结节良恶性鉴别具有一定的敏感度、特异度和准确度。
Objective
     To investigate the value of quantitative analysis of thyroid imaging in the differential diagnosis of thyroid nodule and to provide the basis for further treatment of patients.
     Methods
     Thyroid imaging had been finished for 165 patients with thyroid nodules. According to the pathologic results, thyroid nodules were divided into 131 cases of benign nodules and 34 cases of malignant nodules. Groups of benign nodules were divided into different groups according to different pathological types respectively. The results were analyzed by quantitatively. Then we can obtain cervical arterial-thyroid transit time(CTTT); blood ratio of thyroid nodule and thyroid(TNB/TB); blood ratio of thyroid nodule and carotid artery(TNB/CAB); the ratio of thyroid nodule and salivary gland(TN/SG); the ratio of thyroid nodule and thyroid(TN/T). The difference of quantitative parameter between benign and malignant nodules were compared. The difference of quantitative parameter within the groups of benign nodules were compared.
     Results
     1、Comparing each parameter of thyroid imaging between the malignant and benign nodules
     (1)The CTTT of malignant nodules was lower than that of benign nodules,there was significant difference(P<0.01). The TNB/TB and the TNB/CAB of malignant nodules were higher than that of benign nodules, there were significant differences(P<0.01). The TN/T of malignant nodules was lower than that of benign nodules,there was significant difference(P<0.01).
     (2)The TN/SG of malignant nodules was lower than that of benign nodules, there was no significant difference(P>0.05).
     2. Comparing each parameter of thyroid imaging within the groups of benign nodules
     The CTTT, TNB/TB, TNB/CAB, TN /SG and TN/T were compared within the groups of benign nodules,there were no significant differences(P>0. 0 5).
     3. ROC curve analysis showed that: The sensitivity and specificity of CTTT, TNB/TB, TNB/CAB and TN/T for diagnosis of thyroid nodule were 82.4%, 73.1%; 85.4%, 85.3%; 80%, 61.8%; 85.3%, 66.2% respectively. Combined quantitative parameter of CTTT, TNB/TB, TNB/CAB in thyroid dynamic imaging respectively with TN/T in thyroid static imaging, then the sensitivity, specificity and accuracy for diagnosis of benign and malignant nodules were 67.65%, 90.00%, 85.36%;70.59%, 93.08%, 88.41%;50.00%, 88.45%, 80.49% respectively.
     Conclusions
     1. Quantitative analysis of thyroid imaging has an important value for differential diagnosis thyroid nodule between benign and malignant.
     2. It has a certain degree sensitivity, specificity and accuracy for differential diagnosis thyroid nodule if quantitative parameter in thyroid dynamic imaging combine with that in static imaging.
引文
1赵明,田成功.对恶性甲状腺结节的再认识.医学研究生学报,2009,22(4):418-421.
    2吕坷,姜育新,张缙熙.甲状腺结节的超声诊断研究.中华影像学杂志,2003,12(5):285-287.
    3蒋乐.甲状腺结节的超声诊断与病理对照分析.齐齐哈尔医学院学报,2010,313):386-387.
    4卢姗,马向华,沈捷.甲状腺结节良恶性鉴别的研究进展.医学综述,2010,16(6):859-862.
    5任永芳,杨小丰.甲状腺结节核素显像与病理对照分析.实用医技杂志,1998,5(6):399.
    6宋邦坤,杨吉生,刘斌,等.锝-99m血流显像对甲状腺结节的诊断价值.云南医药,1996: 17 (6): 430-431.
    7杨波,张勇,卢汝虹.甲状腺血流及静态显像鉴别甲状腺结节良恶性的应用分析.昆明医学院学报,2007,28(2):112-113.
    8周莉.甲状腺动态与静态联合显像对甲状腺“冷(凉)结节”的诊断价值.南华大学学报, 2008(2):172-174.
    9叶千春,王淑侠,乔穗宪,等. 99mTc-MIBI甲状腺显像鉴别甲状腺结节良恶性再认识.中华核医学杂志,2006,26(4):20-21.
    10刘晓伟,乌云,顾虹,等. 99mTcO4-甲状腺显像定量分析在甲状腺疾病中的应用.中国冶金工业医学杂志,2004,21(3):184-185.
    11冯钰,高友恭,张长保,等. 119例甲状腺癌核素显像分析.中华核医学杂志,1991,11:38.
    12 Alderson PO,Summer HW,Siegel BA,et al. Single palpable thyroid nodule: Evlu- ation by 99mTcO4- imaging. J Nucl Med,1986, 37: 258.
    13 Freitas JE,Gross MD,Ripley S, et al. Radionuclide diagnosis and therapy of thyroid cancer: current statue report. Semin Nucl Med, 1985, 15(2):106-131.
    14武晓泓,陆晓婕,刘超,等.甲状腺偶发结节的筛查及随访.中国实用内科杂志,2005,25 (9):823-824.
    15刘超,唐伟.甲状腺结节和甲状腺癌的病因学和流行病学.中国实用内科杂志,2007, 27(17):1331~1333.
    16孟娟娟,赵佩琴.甲状腺结节的超声及核素扫描与病理对照分析.现代临床医学生物工程学杂志,1999,5(3):166-167.
    17陈江林,唐淑萍,林兆嫦,等. (99)Tc~m甲状腺扫描对甲状腺结节的诊断价值.实用医技杂志,2004,11(2):196-197.
    18高华,宁磊,牟均青.核素显像对甲状腺结节的诊断价值.中国医学影像学杂志, 2003 ,13(8):607-608.
    19唐明灯,林爱珠,倪雷春,等.核素显像对甲状腺结节诊断意义(附85例分析).福建医药杂志,2001,23(1):152-153.
    20杨波,张勇,卢汝虹,等.甲状腺血流及静态显像鉴别甲状腺结节良恶性的应用分析.昆明医学院学报,2007,(2):112-113.
    21周前.中华影像医学-影像核医学卷.北京:人民卫生出版社,2003:186-190.
    22王伯龄,陈明清.临床核医学.昆明:云南大学出版社,2005:96-103.
    23贺雪珍,孙京凤.核素血管造影诊断甲状腺结节性疾病49例.人民军医,1998,41(3): 152-153.
    24孔桂莲,程俊,孟辉.甲状腺动态与静态联合检查对甲状腺结节性质的判断价值.河南预防医学杂志,1998,9(3):161.
    25 Eds P Amitage,T Colto. Encyclopedia of Biostatistics. Mul Timedia, 1999,6:318-542.
    26李洪林,陈宇,朱利,等.乳腺灰阶与彩色多普勒超声的ROC分析.中国超声医学杂志, 2009,25(3):243-245.
    27宋花玲,贺佳,虞慧婷,等.应用ROC曲线下面积对两相关诊断试验进行评价和比较.第二军医大学学报,2006,27(5):562-563.
    28孔桂莲,马新峰.同位素显像鉴别诊断甲状腺结节性质.医药论坛杂志,2007,28(1):117.
    29周莉.甲状腺动态与静态联合显像对甲状腺“冷(凉)结节”的诊断价值.南华大学学报·医学版,2008(2):172-174.
    30 Bartels PC,Boer RO. Subacute thyroiditis (de Quervain) presenting as a painless“cold”nodules. J Nucl Med,1987,28(9):1488.-1490.
    31武敬平,李建国,赵玉珍,等.超声结合锝-99甲状腺显像对甲状腺结节的诊断价值.中国医疗设备,2008,23(9):157-159.
    32程俊,孔桂莲.甲状腺动态与静态显像联合检查对甲状腺结节性质的判断价值.河南预防医学杂志, 1998,9(3):161.
    1 David S Cooper,Gerard M Doherty, Bryan R Haugen ,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.American Thyroid Associ ation,2006,16(2):109-142.
    2 Tan GH, Gharib H, Reading CC. Solitary thyroid nodule, comparison between palpation and ultrasonography. Arch Intem Med ,1995 ,155(22):2418-2423.
    3 GH Sakorafas ,Peros G, Forley DR. Thyroid nodules: does the suspicion for malignancy really justIfy the increased thyroidectomy rates? Surgoncol, 2006, 15(1): 43-55.
    4 Carlo Cappelli , Maurizio Castellano , Ilenia pirola ,et al. Thyroid nodules shape suggests malignancy European Journal of Endocrinology,2006,155(1):27-31.
    5 Mazzaferri E . Thyroid cancer in thyroid nodules : finding a nodule in the haystack Am J Med,1992,93(4):359-362.
    6.姚斌,柳学.甲状腺结节的诊断与治疗新医学,2005,4(4):189-200.
    7郑泽霖,盖宝东,季德刚.关于甲状腺结节的讨论.中国普通外科杂志,2003.12(10): 721- 722.
    8刘超.规范化处理甲状腺结节,2007全国内分泌学学术会议-代谢综合征与亚临床内分泌代谢疾病论文汇编湖北,武汉,中华医学会、中华医学会内分泌学会主办,2007:36-38.
    9陈如泉.甲状腺疾病的中西医诊断与治疗.北京:中国医药科技出版社,2001(10):721 - 722.3-4, 42 - 46,514.
    10张伯臾.中医内科学上海:上海科学技术出版社,1987,10:218-221.
    11连小兰.美国《甲状腺结节和分化型甲状腺癌诊治指南》(2006)解读.中国实用外科杂志,2007,12:933-934.
    12 Richter B, Neises G, Clar C. Pharmacotherapy for thyroid nodules[J]. Endocrinol Metab Clin North Am, 2002,31(3):699-722.
    13 Jatin P Shan,韩德民,于振坤.头颈外科学与肿瘤学.北京:人民卫生出版社,2005:398.
    14 Papini E,Guqlielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinology Metab,2002,87(5):1941-1946.
    15牛丽娟,郝玉芝,周纯武.超声诊断甲状腺占位性病变的价值.中华耳鼻喉头颈外科杂志, 2006,6:415-418.
    16 Frates MD, Benson MD, Charboneau MD, et al. Management of thyroid nodules detected at us:society of radiologists in ultrasound conference statement. Radiology, 2005, 237: 794-800.
    17 Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands CT and MR imaging and correlation with pathology and clinical findings. Radiologic clinics of North America, 2000, 38(5): 1105 -1129.
    18 Hatabu H, Kasagi K, Yamamoto K, et al. Cystic papillary carcinoma of the thyroid gland: a new sonographic sign. Clin Radiol,1991, 43:120-124.
    19高明,李小龙,于洋,等.甲状腺癌的临床病理及PET-CT的诊断价值.中华耳鼻咽喉头颈外科杂志,2006,41(6):419-424.
    20李前伟,黎川,厉红民,等. 18F-FDG PET/CT探测到早期甲状腺癌1例.第三军医大学学报,2005,27(16):1643-1647.
    21 Elisei R, Bottici V, Luchetti F, et al. Impact of routine measurement of serum calciton- in on the diagnosis and outcome of medullary thyroid cancer: experience in patients with nodulat thyroid disorders.J Clin Endocrinol Metab, 2004,89:163-168.
    22 Jong Ryeal Hahm ,Myung-Shik Lee ,Yong-Ki Min , et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodularthyroid diseases. Thyroid, 2001,11(1):73-80.
    23 Niccoli P,Caron P, Henry JF, et al. Interest of routine measurement of serum calciton- in: study in a large series of thyroidectomized patients.The French Medullary Study Group. The Journal of Clinical Endocrinology& Metablism ,1997,82(8):338-341.
    24 Vlaeminck Guillem V , D herbomez M , Pigny P , et al. Pseudo hypoparathyroidism iaand hypercal citoninemia. J Clin Endocrinol Metab ,2001,86:3091-3096.
    25 Danese D , Sciacchitano S , Farsetti A , et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroi- d,1998 ,8(1):15-21.
    26 Christensen L , Blichert-Toft M , Brandt M , et al. Thyroperoxidase(TPO) immunosta- ining of the solitary cold thyroid nodule. Clin Endocrinol (Oxf), 2000, 53(2):161-169.
    27 Alessandra Gasbarri, Marco Paolo Martegani, Fabrizio Del Prete, et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. Journal of Clinical Oncology,1999, 17(11): 3494-3502.
    28 Carmeci C , Jeffrey RB , McDouqall IR , et al. Ultrasound-guided fine-needle aspirati- on biopsy of thyroid masses. Thyroid, 1998,8(4) :283-289.
    29 Toru Takano , Yasuhiro Ito, Fumio Matsuzuka , et al. Expression of oncofetal fibrone- ctin mRNA in thyroid anaplastic carcinoma. Jpn J Clin Oncol,2007,37(9):647-651.
    30 Catherine B, Katherine W, Baixin Zhu, et al. Classification of follicular thyroid tumors by molecular signature. Clinical Cancer Research ,2003,9:1792-1800.
    31 Cerutti JM,Delcelo R,Nakabashi C,et al. A preoperative diagnostic test that distinguis hes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest, 2004,113(8):1234-1242.
    32施秉银.美国“甲状腺结节和分化性甲状腺癌的诊断治疗指南”解读1.中华内分泌代谢杂志,2006,22(1):306-308.
    33劳丹华,康志强.夏枯草膏治疗结节性甲状腺肿疗效观察.广西医学,2005,27(8): 1255 -1256.
    34朱晓华,于素芳,茹融融,等. 30例女性结节性甲状腺肿的中西医结合治疗.浙江临床医学,2003,5(5):357.
    35刘超,蒋须勤.治疗良性甲状腺结节的新方法-B超导向酒精介入治疗.江苏医药,2000,26(3):33-34.
    36卜子英.甲亢与甲状腺瘤的非手术治疗.北京:人民军医出版社, 2004, 116-119: 168- 171.
    37 Gimm O, Brauckhoff M, Thanh PN, et al. An update on thyroid surgery. Eur Nucl Med,2002, 29(Suppl 2): 447-452.
    38 Colak T, Akca T,Kanik A, et al. Total versus subtotal thyroidectomy for the manage ment of benign multinodular goiter in an endemic region. ANz J Surg, 2004, 74(11): 974-978.
    39 Brennan J, Affleck BD,Swartz K. Surgical considerations and controversies in thyroid and parathyroid surgery. Otolarynqol Clin North Am,2003,36(1):159-187.
    40嵇庆海,马东白.双侧甲状腺乳头状癌术式选择.中国实用外科杂志,2003,23(3): 37-38.
    41马东白.甲状腺外科的进展.中国实用外科杂志,2000,20(1):37.
    42张仑李树玲. 1173例甲状腺乳头状癌外科治疗远期疗效观察.中国肿瘤临床,2006,30 (11):805-806.
    43李树玲.新编头颈肿瘤学.北京:科学技术出版社.2002:1094.
    44吴阶平,裘法祖.皇家驷外科学.第6版.北京:人民卫生出版社,2000:809-823.
    45杨连粤,鲁伟群.扩大患侧甲状腺切除术对孤立性甲状腺结节的疗效评价.中国实用外科杂志,2004,24(1):57-58.
    46边毅,王博林,张永斌.甲状腺结节的术式选择. Modern Oncology,2006,12(3):224-225.
    47 C layman GL,el-Baradie TS. Medullary thyroid cancer. Department of head and Neck Surgery, 2003, 36(1):91-105.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700